Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
PDL 1 immunohistochemistry laboratory validation
Date
07 Oct 2016Session
Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathologyPresenters
Mogens VybergAuthors
M. VybergAuthor affiliations
- Institute Of Pathology, Aalborg University Hospital, 9000 - Aalborg/DK
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
PDL 1 Immunohistochemistry clinical validation with the example of thoracic tumours
Presenter: Solange Peters
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Slides
Webcast
Introduction
Presenter: Peter Schirmacher
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Slides
Webcast
Conclusions and clinical perspectives
Presenter: Rolf A. Stahel
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Webcast
Beyond immunohistochemistry
Presenter: Ian Cree
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.